Revvity | PKI - 债务

股票价格
90.40
每天变化
2.61 2.97%
每月一次
-1.86%
每年
-10.80%
Q2 预测
86.26


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 11.1B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


债务 更改 日
Agilent USD 3.35B 55M 2025-09
Align Technology USD 121.27M 1.75M 2025-09
Bio Techne USD 260M 40M 2025-12
Bio-Rad Laboratories USD 1.4B 11.2M 2025-09
Bruker USD 2.01B 426.8M 2025-09
Celltrion KRW 171.09B 2.05T 2025-06
Charles River Laboratories USD 2.63B 157.4M 2025-09
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Danaher USD 18.42B 1.56B 2025-12
Dentsply International USD 2.48B 14M 2025-09
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Edwards Lifesciences USD 700.3M 2.3M 2025-09
Hologic USD 2.63B 104.3M 2025-09
Illumina USD 2.58B 22M 2025-09
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 15.72B 767M 2025-12
Kangmei Pharma CNY 131.64M 90.18M 2025-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Laboratory Of America USD 6.53B 16.1M 2025-09
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Mesa Laboratories USD 204.98M 7.27M 2024-09
Mettler Toledo International USD 2.21B 25.94M 2025-09
Myriad Genetics USD 59.3M 19.7M 2025-03
Neuren Pharmaceuticals AUD 0 0 2024-12
OraSure Technologies USD 782K 465K 2024-06
Ovoca Bio EUR 0 0 2021-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Pharma Mar EUR 49.42M 1.98M 2025-12
Qiagen NV USD 2.13B 683.16M 2025-09
Quest Diagnostics USD 6.38B 2M 2025-09
Quidel USD 2.84B 51.1M 2025-09
Repligen USD 542.21M 146.65M 2025-12
Revvity USD 3.37B 5.86M 2025-09
Sartorius EUR 4.66B 25.7M 2025-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Thermo Fisher Scientific USD 35.68B 451M 2025-09
Tilray USD 640.95M 35.17M 2022-06
Waters USD 1.49B 52.2M 2025-09
Zz Pientze Pharmaceu CNY 1.07B 52.69M 2025-06